Development and Initial Testing of an mHealth Transitions of Care Intervention for Adults with Schizophrenia-Spectrum Disorders Immediately Following a Psychiatric Hospitalization.
Development and Initial Testing of an mHealth Transitions of Care Intervention for Adults with Schizophrenia-Spectrum Disorders Immediately Following a Psychiatric Hospitalization.
复制标题
精神病住院后立即对精神分裂症谱系障碍成年人进行mHealth过渡护理干预的开发和初步测试。
DOI：
10.1007/s11126-020-09792-9
复制
发表时间：
2021-03
期刊：
影响因子：
--
通讯作者：
Gaudiano BA
中科院分区：
文献类型：
--
作者：
Moitra E;Park HS;Gaudiano BA
An important period in the care of patients with schizophrenia-spectrum disorders is when they transition from inpatient to outpatient services and are at increased risk for relapse and rehospitalization. Thus, we developed and examined the initial feasibility, acceptability, and clinical effects of an mHealth transitions of care intervention (Mobile After-Care Support; MACS) in an open trial. Ten adults with schizophrenia-spectrum disorders were recruited during their index psychiatric hospitalization and enrolled prior to discharge. Measures of feasibility, acceptability, and MACS targets were administered at baseline and a 1-month follow-up. Drawing on skills from Cognitive Behavioral Therapy for Psychosis (CBTp), MACS delivered brief assessments of clinically relevant variables, followed by just-in-time interventions for patients starting immediately post-discharge. Individuals completed about one session per day on average as expected. Overall, measures of MACS usability and satisfaction were positive. T-test analyses showed that dysfunctional coping strategies significantly decreased from baseline to 1-month follow-up. Results also revealed statistically significant reductions in psychiatric symptoms over 1-month follow-up. This study demonstrates the feasibility and acceptability of MACS, a new app-based intervention targeting transitions of care for patients with psychosis. The field is turning to the use of mobile technology as a means of augmenting service delivery and providing real-time assessment and intervention for patients at risk. MACS is a promising adjunctive intervention that warrants further testing in a randomized controlled trial.
登录
查看更多内容
影响因子：
3.2
作者：
Chong HY;Teoh SL;Wu DB;Kotirum S;Chiou CF;Chaiyakunapruk N
通讯作者：
Chaiyakunapruk N
影响因子：
4.5
作者：
Fulford D;Niendam TA;Floyd EG;Carter CS;Mathalon DH;Vinogradov S;Stuart BK;Loewy RL
通讯作者：
Loewy RL
影响因子：
4.5
作者：
Byerly, Matthew J.;Nakonezny, Paul A.;Rush, A. John
通讯作者：
Rush, A. John
影响因子：
4.6
作者：
Farhall, John;Thomas, Neil
通讯作者：
Thomas, Neil
影响因子：
4.4
作者：
Foldemo, A;Gullberg, M;Bogren, L
通讯作者：
Bogren, L